Cargando…
Cytomegalovirus reactivation after CD19 CAR T-cell therapy is clinically significant
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Fondazione Ferrata Storti
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890024/ https://www.ncbi.nlm.nih.gov/pubmed/36263844 http://dx.doi.org/10.3324/haematol.2022.281719 |
| _version_ | 1784880863560859648 |
|---|---|
| author | Chen, George Herr, Megan Nowak, Jan Ho, Christine Almyroudis, Nikolaos Attwood, Kristopher Bonnewell, John Walsh, Marissa Segal, Brahm Ross, Maureen McCarthy, Philip Hahn, Theresa |
| author_facet | Chen, George Herr, Megan Nowak, Jan Ho, Christine Almyroudis, Nikolaos Attwood, Kristopher Bonnewell, John Walsh, Marissa Segal, Brahm Ross, Maureen McCarthy, Philip Hahn, Theresa |
| author_sort | Chen, George |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9890024 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Fondazione Ferrata Storti |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98900242023-02-13 Cytomegalovirus reactivation after CD19 CAR T-cell therapy is clinically significant Chen, George Herr, Megan Nowak, Jan Ho, Christine Almyroudis, Nikolaos Attwood, Kristopher Bonnewell, John Walsh, Marissa Segal, Brahm Ross, Maureen McCarthy, Philip Hahn, Theresa Haematologica Letter to the Editor Fondazione Ferrata Storti 2022-10-20 /pmc/articles/PMC9890024/ /pubmed/36263844 http://dx.doi.org/10.3324/haematol.2022.281719 Text en Copyright© 2023 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
| spellingShingle | Letter to the Editor Chen, George Herr, Megan Nowak, Jan Ho, Christine Almyroudis, Nikolaos Attwood, Kristopher Bonnewell, John Walsh, Marissa Segal, Brahm Ross, Maureen McCarthy, Philip Hahn, Theresa Cytomegalovirus reactivation after CD19 CAR T-cell therapy is clinically significant |
| title | Cytomegalovirus reactivation after CD19 CAR T-cell therapy is clinically significant |
| title_full | Cytomegalovirus reactivation after CD19 CAR T-cell therapy is clinically significant |
| title_fullStr | Cytomegalovirus reactivation after CD19 CAR T-cell therapy is clinically significant |
| title_full_unstemmed | Cytomegalovirus reactivation after CD19 CAR T-cell therapy is clinically significant |
| title_short | Cytomegalovirus reactivation after CD19 CAR T-cell therapy is clinically significant |
| title_sort | cytomegalovirus reactivation after cd19 car t-cell therapy is clinically significant |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890024/ https://www.ncbi.nlm.nih.gov/pubmed/36263844 http://dx.doi.org/10.3324/haematol.2022.281719 |
| work_keys_str_mv | AT chengeorge cytomegalovirusreactivationaftercd19cartcelltherapyisclinicallysignificant AT herrmegan cytomegalovirusreactivationaftercd19cartcelltherapyisclinicallysignificant AT nowakjan cytomegalovirusreactivationaftercd19cartcelltherapyisclinicallysignificant AT hochristine cytomegalovirusreactivationaftercd19cartcelltherapyisclinicallysignificant AT almyroudisnikolaos cytomegalovirusreactivationaftercd19cartcelltherapyisclinicallysignificant AT attwoodkristopher cytomegalovirusreactivationaftercd19cartcelltherapyisclinicallysignificant AT bonnewelljohn cytomegalovirusreactivationaftercd19cartcelltherapyisclinicallysignificant AT walshmarissa cytomegalovirusreactivationaftercd19cartcelltherapyisclinicallysignificant AT segalbrahm cytomegalovirusreactivationaftercd19cartcelltherapyisclinicallysignificant AT rossmaureen cytomegalovirusreactivationaftercd19cartcelltherapyisclinicallysignificant AT mccarthyphilip cytomegalovirusreactivationaftercd19cartcelltherapyisclinicallysignificant AT hahntheresa cytomegalovirusreactivationaftercd19cartcelltherapyisclinicallysignificant |